Amanda Bates, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 936 Jordan Dr, Monticello, AR 71655 Phone: 870-460-0066 |
Mrs. Misty Dawn Jones, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 790 Roberts Drive, Monticello, AR 71655 Phone: 870-367-9732 Fax: 870-460-6133 |
Ginger Marie Maynard, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 790 Roberts Dr, Monticello, AR 71655 Phone: 870-367-2461 Fax: 870-367-1690 |
Anitra Gail Washington, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 790 Roberts Dr, Monticello, AR 71655 Phone: 870-367-2461 Fax: 870-367-0348 |
Michelle A Shirey, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 790 Roberts Dr, Monticello, AR 71655 Phone: 870-367-2461 Fax: 870-367-1690 |
Jessica Rawson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 936 Jordan Dr, Monticello, AR 71655 Phone: 870-460-0066 |
Anita Mariette Spence, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 790 Roberts Dr, Monticello, AR 71655 Phone: 870-367-2461 Fax: 870-367-1690 |
Cynthia Daniels, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 936 Jordan Dr, Monticello, AR 71655 Phone: 870-460-0066 |
Daleshia Martin, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 936 Jordan Dr, Monticello, AR 71655 Phone: 870-460-0066 |
News Archive
The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.
Pitching speed, player's height, and pitching for multiple teams may correlate with a history of shoulder and elbow injuries, according to new research released today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Specialty Day.
A University of Virginia School of Medicine scientist is developing an innovative gene therapy she hopes will slow disease progression and improve movement, coordination and communication in children with Rett syndrome.
Ferrer, a privately-held Spanish pharmaceutical company, today announces the first patient has been recruited into a phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in adult patients with insomnia disorder. The study is scheduled to be completed by Q4, 2016.
Africa's Sahel region is facing a potential "food crisis," "but the good news is that the world's Famine Early Warning System Network (FEWS NET) is giving West African countries and donor nations a period of time to prepare, says the aid group Oxfam," the Christian Science Monitor reports.
› Verified 8 days ago